Analyst Downgrades: Gilead Sciences, Inc., Adeptus Health Inc, and Tableau Software Inc

Analysts downwardly revised their ratings and price targets on Gilead Sciences, Inc. (NASDAQ:GILD), Adeptus Health Inc (NYSE:ADPT), and Tableau Software Inc (NYSE:DATA)

Nov 2, 2016 at 9:56 AM
facebook twitter linkedin

Analysts are weighing in on biotech stock Gilead Sciences, Inc. (NASDAQ:GILD), healthcare concern Adeptus Health Inc (NYSE:ADPT), and tech expert Tableau Software Inc (NYSE:DATA). Here's a quick roundup of today's bearish brokerage notes on GILD, ADPT, and DATA.

  • Analysts are trimming their expectations for GILD, after the company's disappointing quarterly results. For instance, Leerink was one of at least six brokerage firms to cut its price target, lowering its mark to $89 from $94. Of course, that's still well above GILD's current trading level of $72.97, down 1.5% today. Nevertheless, it's been an ugly year for Gilead Sciences, Inc. stock, falling 27%. Making matters worse, it would seem GILD is vulnerable to a round of downgrades, as 11 of 20 brokerage firms recommend buying the shares, and none give them a "sell" rating. 
  • ADPT is plummeting 61.6% to $10.33 -- just off a new record low of $10.10 -- after law firms Johnson & Weaver, LLP and Glancy Prongay & Murray LLP both announced investigations into whether the company violated federal securities laws. Meanwhile, Adeptus Health Inc woefully missed Wall Street's earnings estimates, and said "we have engaged Goldman Sachs to explore various financing alternatives." As such, Jefferies slashed its price target to $13 from $77 and downgraded the stock to "hold" from "buy," while BofA-Merrill Lynch downgraded it to "underperform." Keybanc also chimed its with a price-target cut to $31 from $59. This is all fantastic news for short sellers, though, who control over half of the stock's total float, and who have watched the stock lose roughly 86% of its value since its May high above $73. 
  • DATA is in the midst of a post-earnings slide of its own, as Wall Street punishes the stock for its quarterly revenue miss. No fewer than 18 brokerage firms have already reduced their price targets, with the lowest mark coming from Maxim, at $24. As such, Tableau Software Inc is off 11.9% at $43.61, though it had already been struggling amid overhead pressure from its 200-day moving average -- even as M&A rumors swirl. At the same time, short interest increased by almost 25% in the latest reporting period, so today's sell-off isn't bad news for everyone. 
Find out where the Dow lands right after the closing bell. Sign up now for Schaeffer's Market Recap

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners